Equinoxor vs Kazuya | 41–42 | 49.40% |
Equinoxor vs Reina | 34–37 | 47.89% |
Equinoxor vs Hwoarang | 33–36 | 47.83% |
Equinoxor vs King | 38–28 | 57.58% |
Equinoxor vs Paul | 29–35 | 45.31% |
Equinoxor vs Jin | 29–30 | 49.15% |
Equinoxor vs Bryan | 25–31 | 44.64% |
Equinoxor vs Yoshimitsu | 28–26 | 51.85% |
Equinoxor vs Lidia | 24–27–1 | 47.06% |
Equinoxor vs Alisa | 21–27 | 43.75% |
Equinoxor vs Dragunov | 15–30 | 33.33% |
Equinoxor vs Asuka | 14–30 | 31.82% |
Equinoxor vs Devil Jin | 21–14 | 60.00% |
Equinoxor vs Lili | 15–19 | 44.12% |
Equinoxor vs Nina | 11–22 | 33.33% |
Equinoxor vs Jun | 21–12 | 63.64% |
Equinoxor vs Law | 13–19 | 40.62% |
Equinoxor vs Steve | 24–7 | 77.42% |
Equinoxor vs Lars | 12–15 | 44.44% |
Equinoxor vs Claudio | 15–12 | 55.56% |
Equinoxor vs Victor | 13–13 | 50.00% |
Equinoxor vs Xiaoyu | 10–13 | 43.48% |
Equinoxor vs Feng | 6–17 | 26.09% |
Equinoxor vs Eddy | 13–8 | 61.90% |
Equinoxor vs Heihachi | 4–15 | 21.05% |
Equinoxor vs Lee | 9–6 | 60.00% |
Equinoxor vs Azucena | 5–10 | 33.33% |
Equinoxor vs Leo | 5–7 | 41.67% |
Equinoxor vs Kuma | 4–8 | 33.33% |
Equinoxor vs Raven | 7–5 | 58.33% |
Equinoxor vs Jack-8 | 7–2 | 77.78% |
Equinoxor vs Zafina | 3–5 | 37.50% |
Equinoxor vs Clive | 4–2 | 66.67% |
Equinoxor vs Leroy | 1–4 | 20.00% |
Equinoxor vs Panda | 1–2 | 33.33% |
Equinoxor vs Shaheen | 0–2 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.